Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST)

Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST)

<p>Abstract</p> <p>Background</p> <p>The use of imatinib mesylate is associated with a progression free survival of 41 months in first line treatment of metastatic or locally advanced gastrointestinal stromal tumors (GIST) and other studies approved that adjuvant imatin...

Full description

Bibliographic Details
Main Authors: Seidel Christoph, Fenner Martin, Länger Florian, Bantel Heike, Ganser Arnold, Grünwald Viktor
Format: Article
Language:English
Published: BMC 2012-05-01
Series:BMC Cancer
Subjects:
GIST
Imatinib
Liver cirrhosis
Online Access:http://www.biomedcentral.com/1471-2407/12/186

Similar Items

Similar Items